GGrantIndex
Sort

326,823 grants matching clinical trial

Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

$1,887,573
Andrea Lynne Gropman · Children'S Research Institute · U54 · FY2019 · HD

Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication

$1,887,460
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2025 · AI

NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines

$1,887,453
Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI

MOCSLID-DCC

$1,887,334
Robert M Elashoff · University Of California Los Angeles · R01 · FY2008 · HL

CLIN AND BIOLOGIC STUDIES OF EARLY ALZHEIMERS DISEASE

$1,887,214
Mount Sinai School Of Medicine Of Nyu · P01 · FY2002 · AG

Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) DCC

$1,886,965
Christopher S. Coffey · University Of Iowa · U01 · FY2024 · NS

ADULT AIDS CLINICAL TRIALS UNIT

$1,886,782
Washington University · U01 · FY2000 · AI

SAN DIEGO AIDS CLINICAL TRIAL UNIT

$1,886,558
University Of California San Diego · U01 · FY2001 · AI

Collaborative Care for Chronic Pain in Primary Care

$1,886,306
Lynn Larson Debar · Kaiser Foundation Research Institute · UH3 · FY2016 · NS

CANCER RESEARCH CENTER OF HAWAII

$1,886,086
University Of Hawaii At Manoa · P30 · FY2003 · CA

Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial

$1,886,003
Badih Joseph Elmunzer · Medical University Of South Carolina · U01 · FY2015 · DK

Radiosurgery vs lobectomy for temporal lobe epilepsy: Phase 3 Clinical Trial

$1,885,688
Nicholas M Barbaro · University Of California, San Francisco · U01 · FY2011 · NS

ACE: Translational Studies of Insistence on Sameness in Autism

$1,885,481
Edwin H Cook · University Of Illinois At Chicago · P50 · FY2008 · HD

Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy

$1,885,349
Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Host-tumor cell interaction in myeloma: therapeutic applications

$1,885,301
Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2014 · CA

The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas

$1,885,277
Robert Wolff · University Of Tx Md Anderson Can Ctr · U10 · FY2013 · CA

TOBACCO EXPOSURE REDUCTION

$1,885,029
University Of Minnesota Twin Cities · P50 · FY2000 · DA

GENE THERAPY FOR SICKLE CELL ANEMIA

$1,884,934
Yeshiva University · P01 · FY2002 · HL

Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy

$1,884,922
Joseph J Cullen · University Of Iowa · P01 · FY2019 · CA

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

$1,884,842
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

NORMAL & NEOPLASTIC GROWTH IN THE BRAIN

$1,884,764
Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2021 · CA

Developmental Funds

$1,884,695
Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2016 · CA

Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network

$1,884,695
Michelle M Mielke · Wake Forest University Health Sciences · U24 · FY2023 · AG

GVL without GVHD across HLA barriers: Translational Studies

$1,884,598
Megan Sykes · Massachusetts General Hospital · P01 · FY2007 · CA

Kaiser Washington Vaccine and Treatment Evaluation Unit

$1,884,389
Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2020 · AI